Drug Information
| General Information | ||||||
|---|---|---|---|---|---|---|
| Drug ID |
DR00139
|
|||||
| Drug Name |
Alpha-ketoglutaric acid
|
|||||
| Synonyms |
2-Oxoglutarate; 2-ketoglutarate; 2-ketoglutaric acid; alpha-ketoglutarate; oxoglutarate
|
|||||
| Drug Type |
Small molecular drug
|
|||||
| Indication | Discovery agent [ICD11: N.A.] | Investigative | ||||
| Structure |
|
 |
||||
| 3D MOL | 2D MOL | |||||
| Formula |
C5H6O5
|
|||||
| Canonical SMILES |
C(CC(=O)O)C(=O)C(=O)O
|
|||||
| InChI |
InChI=1S/C5H6O5/c6-3(5(9)10)1-2-4(7)8/h1-2H2,(H,7,8)(H,9,10)
|
|||||
| InChIKey |
KPGXRSRHYNQIFN-UHFFFAOYSA-N
|
|||||
| CAS Number |
CAS 328-50-7
|
|||||
| Pharmaceutical Properties | Molecular Weight | 146.1 | Topological Polar Surface Area | 91.7 | ||
| Heavy Atom Count | 10 | Rotatable Bond Count | 4 | |||
| Hydrogen Bond Donor Count | 2 | Hydrogen Bond Acceptor Count | 5 | |||
| XLogP |
-0.9
|
|||||
| PubChem CID | ||||||
| PubChem SID |
10319709
, 10322722
, 10518773
, 11405806
, 11459129
, 11459622
, 11532715
, 14710598
, 14710663
, 14716068
, 14716122
, 15321557
, 17389187
, 17424980
, 22390397
, 24438432
, 24698269
, 24844201
, 24844229
, 24875185
, 24896202
, 24896211
, 3133601
, 3328
, 4252672
, 6312360
, 7885202
, 7885817
, 8026183
, 80706
, 8138018
, 8145356
, 8150433
, 820888
, 820890
, 820952
, 821199
, 821363
, 821365
, 826540
, 827040
, 828687
, 828688
, 828690
, 836159
, 837490
, 837495
, 837496
, 837918
, 841741
|
|||||
| ChEBI ID |
CHEBI:30915
|
|||||
| TTD Drug ID | ||||||
| DT(s) Transporting This Drug | NaCT | Transporter Info | Sodium-coupled citrate transporter | Substrate | [1] | |
| NADC3 | Transporter Info | Sodium/dicarboxylate cotransporter 3 | Substrate | [2] | ||
| ODC | Transporter Info | Mitochondrial 2-oxodicarboxylate carrier | Substrate | [3] | ||
| OGC | Transporter Info | Mitochondrial 2-oxoglutarate/malate carrier | Substrate | [4] | ||
| Drug-Transporter Activity Data | ||||||
| Drug-Transporter Activity Data | NADC3 | Transporter Info | Km = 149 microM | HEK293T cells-NADC3 | [2] | |
| References | ||||||
| 1 | SLC13 family of Na+ coupled di- and tri-carboxylate/sulfate transporters. Mol Aspects Med. 2013 Apr-Jun;34(2-3):299-312. | |||||
| 2 | SLC13A3 variants cause acute reversible leukoencephalopathy and -ketoglutarate accumulation. Ann Neurol. 2019 Mar;85(3):385-395. | |||||
| 3 | Mitochondrial oxodicarboxylate carrier deficiency is associated with mitochondrial DNA depletion and spinal muscular atrophy-like disease. Genet Med. 2018 Oct;20(10):1224-1235. | |||||
| 4 | The mitochondrial dicarboxylate and 2-oxoglutarate carriers do not transport glutathione. FEBS Lett. 2015 Feb 27;589(5):621-8. | |||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.